Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -70.69%489.79K | -65.08%697.62K | -171.30%-956.69K | 2,982.72%7.12M | 3.45%2.11M | 22.94%1.67M | 36.74%2M | 54.98%1.34M | -88.47%231.11K | 200.07%2.04M |
| Net income from continuing operations | 524.91%2.84M | 118.75%1.42M | 125.94%1.08M | -1,690.77%-10.7M | 184.97%1.71M | -293.13%-667.24K | -1,938.40%-7.57M | -803.03%-4.17M | 60.12%672.43K | -345.57%-2.01M |
| Operating gains losses | -208.50%-1.75M | -120.93%-1.65M | -129.40%-1.56M | 1,595.67%9.62M | -237.75%-5.18M | 237.76%1.61M | 2,838.09%7.9M | 4,955.63%5.29M | -43.41%-643.19K | 166,404.20%3.76M |
| Depreciation and amortization | -19.04%657.19K | -18.20%635.1K | -18.99%562.8K | 636.71%2.92M | -7.28%637.48K | 15.19%811.74K | 40.69%776.42K | 77.12%694.68K | -78.61%396.4K | -6.27%687.56K |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | --0 |
| Remuneration paid in stock | 78.89%527.39K | 2,293.86%674.73K | 1,266.22%767.61K | 1,152.03%1.31M | 853.60%927.43K | 206.61%294.81K | -70.51%28.19K | 1.01%56.19K | -11.49%104.36K | 943.97%97.26K |
| Deferred tax | --0 | 74.08%-13.46K | 42.99%-53.16K | -101.93%-4.33K | --449.55K | ---308.7K | ---51.92K | ---93.25K | --224.06K | ---- |
| Other non cashItems | -63.78%-959.04K | -1,531.63%-1.05M | 1,171.29%233.03K | 26,670.11%2.58M | 668.71%3.12M | -348.60%-585.55K | -82.46%73.16K | -115.54%-21.75K | -101.08%-9.73K | -228.20%-548.37K |
| Change In working capital | -259.89%-822.06K | -19.56%681.81K | -371.19%-1.99M | 371.64%1.39M | -13.55%454.87K | 202.85%514.15K | 398.32%847.62K | -0.77%-422.53K | 56.18%-513.22K | 1,572.38%526.17K |
| -Change in receivables | ---- | ---- | 13.25%-416.67K | -90.12%46.08K | 538.29%1.06M | ---- | ---- | -230.73%-480.32K | 151.56%466.43K | 126.24%166.77K |
| -Change in inventory | ---- | ---- | 56.08%-191.84K | 43.99%-192.84K | 2.48%-387.52K | ---- | ---- | 19.39%-436.78K | -263.98%-344.31K | -240.55%-397.36K |
| -Change in prepaid assets | ---- | ---- | -894.08%-415.44K | -1,510.49%-443.67K | -301.29%-146.88K | ---- | ---- | 619.48%52.32K | -623.05%-27.55K | 77.82%72.97K |
| -Change in payables and accrued expense | ---- | ---- | -366.03%-1.18M | 382.11%1.71M | -144.71%-345.1K | ---- | ---- | 270.72%442.26K | -644.09%-607.8K | 177.06%771.91K |
| -Change in other current liabilities | ---- | ---- | --209.54K | --269.88K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Change in other working capital | ---- | ---- | --209.54K | ---- | ---- | ---- | ---- | ---- | ---- | -3,462.09%-88.13K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -70.69%489.79K | -65.08%697.62K | -171.30%-956.69K | 2,982.72%7.12M | 3.45%2.11M | 22.94%1.67M | 36.74%2M | 54.98%1.34M | -88.47%231.11K | 200.07%2.04M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 79.35%-687.26K | 81.75%-546.37K | 77.75%-722.14K | -965.06%-12.2M | -35.55%-2.63M | -591.20%-3.33M | -598.12%-2.99M | -8,821.08%-3.25M | -2.87%-1.15M | -573.10%-1.94M |
| Net PPE purchase and sale | 29.12%-524.3K | -101.67%-464.83K | 77.34%-67.36K | -1,272.65%-1.74M | 34.61%-471.48K | -173.58%-739.72K | 46.27%-230.5K | -717.29%-297.31K | 88.60%-126.69K | -150.11%-721.06K |
| Net business purchase and sale | -50.84%-634.91K | ---211.54K | ---43.29K | ---2.78M | ---213.29K | ---420.91K | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --211.04K |
| Dividends received (cash flow from investment activities) | -137.50%-45K | ---- | ---- | ---530K | ---530K | --120K | ---- | ---- | --0 | ---- |
| Net other investing changes | 122.60%516.96K | 140.25%200K | 79.26%-611.49K | -601.71%-7.15M | ---1.42M | ---2.29M | ---496.87K | ---2.95M | ---1.02M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 79.35%-687.26K | 81.75%-546.37K | 77.75%-722.14K | -965.06%-12.2M | -35.55%-2.63M | -591.20%-3.33M | -598.12%-2.99M | -8,821.08%-3.25M | -2.87%-1.15M | -573.10%-1.94M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,576.59%4.04M | 54.23%-427.68K | 43.35%6.53M | 358.99%2.95M | -244.10%-392.86K | -107.17%-273.56K | -27.77%-934.44K | 322.94%4.55M | -169.68%-1.14M | 179.95%272.63K |
| Net issuance payments of debt | 1,002.45%4.4M | 18.56%-680K | 859.54%6.64M | -139.30%-2.73M | -294.54%-530.36K | -112.79%-487.91K | -14.17%-834.95K | -181.16%-873.57K | 33.85%-1.14M | 179.95%272.63K |
| Net common stock issuance | ---- | ---- | ---- | ---126.91K | ---- | ---- | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | 1,330.50%392.31K | -99.72%13.55K | --5.02M | --0 | --164.35K | --27.43K | --4.83M | --0 | ---- |
| Net other financing activities | -827.63%-363.81K | -10.31%-140K | -120.56%-123.37K | --787.5K | --264.41K | --50K | ---126.91K | --600K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,576.59%4.04M | 54.23%-427.68K | 43.35%6.53M | 358.99%2.95M | -244.10%-392.86K | -107.17%-273.56K | -27.77%-934.44K | 322.94%4.55M | -169.68%-1.14M | 179.95%272.63K |
| Net cash flow | ||||||||||
| Beginning cash position | 23.00%9.25M | 0.80%9.53M | -31.19%4.68M | -23.18%6.8M | -34.08%5.59M | 98.53%7.52M | 171.01%9.45M | 330.02%6.8M | 695.15%8.86M | 454.17%8.48M |
| Current changes in cash | 299.04%3.84M | 85.69%-276.43K | 82.99%4.85M | -3.34%-2.12M | -342.22%-909.5K | -141.12%-1.93M | -742.09%-1.93M | 38.98%2.65M | -538.49%-2.05M | 626.64%375.48K |
| End cash Position | 134.17%13.09M | 23.00%9.25M | 0.80%9.53M | -31.19%4.68M | -47.14%4.68M | -34.08%5.59M | 98.53%7.52M | 171.01%9.45M | 330.02%6.8M | 459.80%8.86M |
| Free cash from | -103.71%-34.51K | -86.83%232.79K | -198.05%-1.02M | 5,057.52%5.39M | 24.20%1.64M | -14.46%931.29K | 71.24%1.77M | 25.93%1.04M | -88.31%104.42K | 236.75%1.32M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.